Transdifferentiation of pancreas to liver is a well-recognized phenomenon and has been described in animal experiments and human pathology. We recently produced an in vitro model for the transdifferentiation (or conversion) of the pancreatic cell line AR42J-B13 to hepatocytes based on culture with dexamethasone (Dex). To determine whether the hepatocytes express markers of hepatic intermediary metabolism and detoxification, we investigated the patterns of expression of glucokinase, cytochrome P450s CYP3A1 and CYP2B1/2, testosterone/4-nitrophenol uridine diphosphate glucuronosyltransferase (UDPGT), and aryl sulfotransferase. All were expressed. We also determined the expression of 2 enzymes involved in ammonia detoxification: carbamoylphosphate synthetase I (CPS I) and glutamine synthetase (GS). These enzymes are normally strictly compartmentalized in liver in a wide periportal pattern and the last downstream perivenous hepatocytes, respectively. Following culture with Dex, CPS I and GS are expressed in 2 different cell populations, suggesting that both periportal and perivenous hepatocytes are induced. We also produced a reporter assay based on the activation of green fluorescent protein (GFP) by the transthyretin (TTR) promoter or glucose-6-phosphatase (G6Pase) promoter. After culture with Dex, transfected cells begin to express GFP, showing that hepatic promoters are activated in concert with the induction of the hepatocyte phenotype. Lastly, we examined the stability of the hepatic phenotype and found that some cells still express liver markers (transferrin or albumin) up to 14 days after removal of Dex. In conclusion, these results suggest that pancreatic hepatocytes produced by this method may offer an alternative model to primary cultures of hepatocytes for the study of liver function. (HEPATOLOGY 2002;36:534-543.) I n vitro cultures of hepatocytes offer a valuable tool in the investigation of liver function. However, the major limitation to the use of cultured hepatocytes is their rapid loss of differentiated properties and gain of a more fetal/neoplastic phenotype. 1-3 For example, the loss of differentiated phenotype is most apparent in the rapid decline of total cytochrome P450 (CYP) after isolation and in culture, particularly the CYP3A1 isoform. 2 Dedifferentiation is reflected not only in decreased liver-specific functions but also in an alteration of morphology; the cells flatten, depolarize, and lose many of the surface characteristics of normal hepatocytes in vivo. The mechanisms responsible for loss of differentiated properties include down-regulation of transcription factors (e.g., C/EBP␣ and HNF1) involved in liver-specific gene expression and a switch from a quiescent to a proliferative mode. 2 It is also difficult to examine the long-term effects of exogenous factors on hepatic gene expression and liver function. Culture conditions that maintain primary rat hepatocytes in a highly differentiated state have recently been developed, but these still have selective expression of hepatic marke...